Pharmaceutics · 2019 · 11 citations · 23 references
MedicineGeriatric MedicinePharmacologyAgingGeriatricsGerontologyGeriatric Pharmaceutical CareMedication UsePharmacoepidemiologyPolypharmacy AssessmentPolypharmacy ConsiderationsPolypharmacy ManagementAge-appropriate Drug FormulationsAge-based PrescribingBenefit-risk RatioElderly Medication ManagementGeriatric Drug DevelopmentOlder Adult PopulationRisk-benefit Ratio Assessment
A meeting organised by the Academy of Pharmaceutical Sciences focussed on the challenges of developing medicines for older adults. International experts discussed the complexity introduced by polypharmacy and multiple morbidities and how the risk⁻benefit ratio of a medicine changes as an individual ages. The way in which regulatory authorities are encouraging the development of age-appropriate medicines was highlighted. Examples were provided of the difficulties faced by the older population with some medicinal products and suggestions given as to how the pharmaceutical scientist can build the requirements of the older population into their development of new medicines, as well as improvements to existing ones.
23
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
Munir Pirmohamed, Sally James, Shaun Meakin et al. · BMJ · 2004 · 3.2K citations · Full text
The number needed to treat: a clinically useful measure of treatment effect
Richard J. Cook, D L Sackett · BMJ · 1995 · 1.9K citations
Quantification of biological aging in young adults
Daniel W. Belsky, Avshalom Caspi, Renate Houts et al. · Proceedings of the National Academy of Sciences · 2015 · 1K citations · Full text
Education, Physiology, Aging +16
The increasing burden and complexity of multimorbidity
Anna Koné, Susan E. Bronskill, Andrea Gruneir et al. · BMC Public Health · 2015 · 640 citations · Full text
Public Health, Geriatric Medicine, Clinical Epidemiology +14